A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels.

TitleA membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels.
Publication TypeJournal Article
Year of Publication2024
AuthorsPapa A, Morfin PJDel Rive, Chen B-X, Yang L, Katchman AN, Zakharov SI, Liu G, Bohnen MS, Zheng V, Katz M, Subramaniam S, Hirsch JA, Weiss S, Dascal N, Karlin A, Pitt GS, Colecraft HM, Ben-Johny M, Marx SO
JournalJ Clin Invest
Volume134
Issue5
Date Published2024 Jan 16
ISSN1558-8238
KeywordsAdrenergic Agents, Arrhythmias, Cardiac, Calcium, Calcium Channels, L-Type, Humans, Monomeric GTP-Binding Proteins, Myocytes, Cardiac
Abstract

The ability to fight or flee from a threat relies on an acute adrenergic surge that augments cardiac output, which is dependent on increased cardiac contractility and heart rate. This cardiac response depends on β-adrenergic-initiated reversal of the small RGK G protein Rad-mediated inhibition of voltage-gated calcium channels (CaV) acting through the Cavβ subunit. Here, we investigate how Rad couples phosphorylation to augmented Ca2+ influx and increased cardiac contraction. We show that reversal required phosphorylation of Ser272 and Ser300 within Rad's polybasic, hydrophobic C-terminal domain (CTD). Phosphorylation of Ser25 and Ser38 in Rad's N-terminal domain (NTD) alone was ineffective. Phosphorylation of Ser272 and Ser300 or the addition of 4 Asp residues to the CTD reduced Rad's association with the negatively charged, cytoplasmic plasmalemmal surface and with CaVβ, even in the absence of CaVα, measured here by FRET. Addition of a posttranslationally prenylated CAAX motif to Rad's C-terminus, which constitutively tethers Rad to the membrane, prevented the physiological and biochemical effects of both phosphorylation and Asp substitution. Thus, dissociation of Rad from the sarcolemma, and consequently from CaVβ, is sufficient for sympathetic upregulation of Ca2+ currents.

DOI10.1172/JCI176943
Alternate JournalJ Clin Invest
PubMed ID38227371
PubMed Central IDPMC10904049
Grant ListS10 RR027050 / RR / NCRR NIH HHS / United States
R01 HL155377 / HL / NHLBI NIH HHS / United States
R01 HL146149 / HL / NHLBI NIH HHS / United States
P30 CA013696 / CA / NCI NIH HHS / United States
R01 HL121253 / HL / NHLBI NIH HHS / United States
R01 HL140934 / HL / NHLBI NIH HHS / United States
P01 HL164319 / HL / NHLBI NIH HHS / United States
F31 HL158232 / HL / NHLBI NIH HHS / United States